Perchetti, Garrett A. http://orcid.org/0000-0003-3786-0509
Biernacki, Melinda A.
Xie, Hu
Castor, Jared
Joncas-Schronce, Laurel
Ueda Oshima, Masumi http://orcid.org/0000-0003-2277-1976
Kim, YoungJun
Jerome, Keith R. http://orcid.org/0000-0002-8212-3789
Sandmaier, Brenda M. http://orcid.org/0000-0002-9767-9739
Martin, Paul J. http://orcid.org/0000-0001-9051-1215
Boeckh, Michael
Greninger, Alexander L.
Zamora, Danniel http://orcid.org/0000-0002-1318-2902
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1K23AI163343-01A1, CA078902, CA15704, CA15704, 1K23AI163343-01A1, CA15704, 1K23AI163343-01A1, CA078902)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 26 May 2022
Revised: 8 January 2023
Accepted: 12 January 2023
First Online: 24 January 2023
Competing interests
: All authors report grant support from the NIH (CA15704 and CA078902) and Fred Hutchinson Cancer Center (Fred Hutch) during the conduct of the study. DZ reports additional support from The Joel Meyers Endowment Scholarship and from the NIH (1K23AI163343–01A1). PJM has served on advisory boards or consulted for Neovii Biotech GmbH, Genentech, Enlivex Therapeutics, Mesoblast and Pharmacyclics and has received institutional research funding from AltruBio. PJM provided an invited lecture, sponsored by Janssen, to the 2019 meeting of the Israeli Society of Hematology and Transfusion Medicine; Janssen had no input regarding the content of the lecture. Funding was used solely for travel costs and housing directly related to the meeting; all arrangements were made by a third party, and he did not receive an honorarium. KRJ reports contract testing from Abbott. ALG reports contract testing from Abbott, Cepheid, Novavax, Pfizer, Janssen, Hologic, and research support from Gilead and Merck, outside of the described work. MB has received research support from Astellas, Gilead Sciences, Shire Pharmaceutical (now known as Takeda), and Merck & Co Inc; and personal fees from Merck & Co. Inc., Allovir, and SymBio; and personal fees and nonfinancial support from EvrysBio; all outside of the submitted work. The remaining authors have no additional conflicts of interest to disclose.